Furthermore, treatment with SEL001 decreased the expression level of psoriasis-associated pro-inflammatory cytokines, such as IL-17A, IL-19, and IL-23, proposing that altogether these changes might be mediators of the positive effects of SEL001 observed in the psoriasis-like skin inflammation model used in this study. The gene discussed is IL17A; the disease is psoriasis.